Alvogen to Purchase Medicines Producer in South Korea

Font size AAA
07 Aug 2014 16:38 Helen Clark

CHEMMONITOR.COM – Alvogen, a multinational pharmaceuticals company headquartered in the USA, has bought Dream Pharma (South Korea) for USD 187 million. The purchase will be closed in Q4 2014.The acquisition will enable Alvogen to become one of the five top drugs producers on the APAC market.

03 Feb
Arlanxeo to Start Chloroprene Rubber Capacity Expansion in Q2 2018
03 Feb
Nippon Shokubai to Raise Production Capacities at Three Plants
03 Feb
Grupo Antolín Irausa to Build Three New Plants in the USA
26 Jan
SK Global Chemical Shuts No. 2 Naphtha Cracker in Ulsan
26 Jan
Perlen Packaging to Purchase Stake in Sekoya Indústria e Comércio